Home › Malattie polmonari interstiziali › Illinois › Chicago
Studi clinici su Malattie polmonari interstiziali a Chicago, IL
12 studi su Malattie polmonari interstiziali cercano partecipanti presso sedi a Chicago e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Pulmonary Fibrosis Foundation Community Registry
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Pulmonary Fibrosis Foundation, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
In reclutamentoFase 2/3
- GSK Investigational Site, Chicago
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
In reclutamento
- Northwestern University, Chicago
- University of Illinois Health, Chicago
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
In reclutamentoFase 3
- Northwestern University, Chicago
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
In reclutamentoFase 2
- Clinical Research Site, Chicago
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
In reclutamentoStudio osservazionale
- Northwestern University, Chicago
Platform Clinical Study for Conquering Scleroderma
In reclutamentoFase 2
- The University of Chicago Medical Center (UCMC), Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
In reclutamentoFase 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
In reclutamentoStudio osservazionale
- University of Chicago, Chicago
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
In reclutamentoFase 3
- Northwestern Memorial Hospital, Clinical Research Unit, Chicago
- Rush University Medical Center Outpatient Pulmonary Clinic, Chicago
- UI Health Hospital, Chicago
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- University of Chicago, Chicago
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
In reclutamentoFase 2
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
Studi su Malattie polmonari interstiziali in altre città
- New York City, NY18 studi
- Philadelphia, PA16 studi
- Los Angeles, CA14 studi
- Kansas City, KS13 studi
- Durham, NC13 studi
- Charleston, SC13 studi
- Houston, TX12 studi
- Ann Arbor, MI11 studi
- Aurora, CO11 studi
- Phoenix, AZ9 studi
- Salt Lake City, UT9 studi
- Boston, MA9 studi
Altri studi a Chicago
- Cancro del polmone non a piccole cellule61 studi
- Cancro al seno58 studi
- Cancro (tutti i tipi)51 studi
- Cancro metastatico45 studi
- Cancro alla prostata45 studi
- Obesità41 studi
- Cancro ai polmoni41 studi
- Cancro ovarico36 studi
- Ictus34 studi
- Cancro colorettale33 studi
- Insufficienza cardiaca31 studi
- Sovrappeso28 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.